Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use EOHILIA safely and effectively. See full prescribing information for EOHILIA. EOHILIA™ (budesonide oral suspension) Initial U.S. Approval: 1997
Medication labelWhy this: Advisory · dailymed-prescription
EOHILIA™ is indicated for 12 weeks of treatment in adult and pediatric patients 11 years of age and older with eosinophilic esophagitis (EoE). Limitations of Use EOHILIA has not been shown to be safe and effective for the treatment of EoE for longer than 12 weeks [see Dosage and Administration (2.1), Clinical Studies (14)].
- generic_name
- budesonide
- product_names
- Budesonide
- ndc
- 64764-105, 64764-105-10, 64764-105-60, 64764-105-01, 64764-105-00
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en